Ozenoxacin
1 Inquiries
245765-41-7
1g/bag
2021-08-15
API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceOzenoxacin is used to treat impetigo (a skin infection caused by bacteria) in adults and children 2 months of age and older. Ozenoxacin is in a class of medications called antibacterials. It works by killing and stopping the growth of bacteria on the skin. To date, ozenoxacin has been used in trials studying the treatment of impetigo. As of December 11, 2017 the FDA approved Ferrer Internacional S.A.'s Xepi (ozenoxacin 1%) as a topically applied cream indicated for the treatment of impetigo caused by Staphylococccus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older.
Ozenoxacin is a novel, nonfluorinated quinolone antibiotic discovered by Toyama Chemical Co. Ltd. and developed by Maruho Co. Ltd. Ozenoxacin was approved by the PMDA of Japan in September 2015 for the treatment of acne and skin infections. Ozenoxacin shows potent antibacterial activity against anaerobic and aerobic, gram-positive and -negative bacteria, especially those implicated in superficial skin infections such as S. aureus, Staphylococcus epidermidis, and Propionibacterium acnes. The mechanism of action of ozenoxacin involves the drug’s affinity for DNA gyrase and DNA topoisomerase IV and upon binding triggers bacterial apoptosis.
ChEBI: Ozenoxacin is a member of quinolines.Basic Info-
Product Name:
Ozenoxacin
Other Name:Ozenoxacin;T 3912;:3-Quinolinecarboxylic acid, 1-cyclopropyl-1,4-dihydro-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-;Ozenoxacin(T 3912);1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)pyridin-3-yl]-4-oxoquinoline-3-carboxylic acid;Ozenoxacin , T 3912,UNII-V0LH498RFO;Ozenoxacin Impurity 1;organic materials Ozenoxacin
CAS No.:245765-41-7
Molecular Formula:C21H21N3O3
InChIKeys:XPIJWUTXQAGSLK-UHFFFAOYSA-N
Molecular Weight:363.41
Exact Mass:363.41
EC Number:105-745-2
Color/Form:Off-White
Categories:
Characteristics-
Density:
1.372±0.06 g/cm3(Predicted)
Melting Point:>255°C (dec.)
Boiling Point:573.5±50.0 °C(Predicted)
PKA:6.46±0.50(Predicted)
Critical Temperature & Pressure:2-8°C(protect from light)
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30 days
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.
Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.
Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
India
Ozenoxacin
1 MT Jul 4, 2025 Post an enquiry for this product
More from this Seller
-
-
![Vonoprazan]( "Vonoprazan")
-
Vonoprazan
Pharmaceutical Grade / 99%
-
-
-
![4-(6-amino-3-pyridinyl)-, 1,1-dimethylethyl ester]( "4-(6-amino-3-pyridinyl)-, 1,1-dimethylethyl ester")
-
4-(6-amino-3-pyridinyl)-, 1,1-dimethylethyl ester
Pharmaceutical Grade / 99%
-
-
-
![Ticagrelor intermediate 1156491-10-9 99.0% Powder Echemi]( "Ticagrelor intermediate 1156491-10-9 99.0% Powder Echemi")
-
Ticagrelor intermediate 1156491-10-9 99.0% Powder Echemi
Pharmaceutical Grade / 99.0%
-
-
-
![Semaglutide]( "Semaglutide")
-
Semaglutide
Pharmacy Grade / 99%
-
-
-
![3,6-Dihydro-3-methyl-N-nitro-2H-1,3,5-oxadiazin-4-amine]( "3,6-Dihydro-3-methyl-N-nitro-2H-1,3,5-oxadiazin-4-amine")
-
3,6-Dihydro-3-methyl-N-nitro-2H-1,3,5-oxadiazin-4-amine
Pesticide Grade / 99%
-
-
-
![Diflubenzuron]( "Diflubenzuron")
-
Diflubenzuron
Technical / 99%
-
